Lupin gets USFDA’s approval for Fluoxetine Tablets

16 Apr 2019 Evaluate

Lupin has received approval for its Fluoxetine Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Eli Lilly and company’s (Eli Lilly) Prozac Tablets, 10 mg and 20 mg.

The company’s Fluoxetine Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly’s Prozac Tablets, 10 mg and 20 mg. Fluoxetine Tablets, 10 mg and 20 mg, (RLD: Prozac) had annual sales of approximately $68.2 million in the US (IQVIA MAT December 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2313.20 -21.75 (-0.93%)
30-Mar-2026 13:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.60
Dr. Reddys Lab 1262.00
Cipla 1227.65
Zydus Lifesciences 884.00
Lupin 2313.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×